Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001535610-16-000115
Filing Date
2016-01-12
Accepted
2016-01-12 14:57:37
Documents
1

Document Format Files

Seq Description Document Type Size
1 SABBY 13G-A XTLB 1.12.16 xtlb0116.txt SC 13G/A 13601
  Complete submission text file 0001535610-16-000115.txt   15143
Mailing Address 85 MEDINAT HAYEHUDIM ST. PITUACH, PO BOX 4033 HERZLIYA L3 46140
Business Address XTL BIOPHARMACEUTICALS LTD C/O ALSTON & BIRD LLP, 90 PARK AVENUE NEW YORK NY 10016 972 9 955 7080
XTL BIOPHARMACEUTICALS LTD (Subject) CIK: 0001023549 (see all company filings)

EIN.: 000000000
Type: SC 13G/A | Act: 34 | File No.: 005-83127 | Film No.: 161338589
SIC: 2834 Pharmaceutical Preparations

Mailing Address 10 MOUNTAINVIEW ROAD SUITE 205 UPPER SADDLE RIVER NJ 07458
Business Address 10 MOUNTAINVIEW ROAD SUITE 205 UPPER SADDLE RIVER NJ 07458 646-307-4527
SABBY MANAGEMENT, LLC (Filed by) CIK: 0001535610 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A